Nitrous oxide produces antinociceptive response via α(2B) and/or α(2C) adrenoceptor subtypes in mice

Anesthesiology

Volumn 90, Issue 2, 1999, Pages 470-476

  Guo, Tian Zhi ^a   Davies, M Frances ^a   Kingery, Wade S ^a,b   Patterson, Andrew J ^a   Limbird, Lee E ^c   Maze, Mervyn ^a,d  

^a STANFORD UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Analgesia; Opiate receptors; Tail flick

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; NITROUS OXIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANESTHETICS, INHALATION; ANIMALS; MALE; MICE; MICE, TRANSGENIC; NITROUS OXIDE; PAIN; RATS; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0032911410     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199902000-00022     Document Type: Article

References (39)

1. Davy H: Researches, chemical and philosophical; chiefly concerning nitrous oxide, or dephlogisticated nitrous air, and its respiration. London, Biggs and Cottle for J. Johnston, 1800
2. Chapman WP, Arrowood JG, Beecher HK: The analgetic effects of low concentrations of nitrous oxide compared in man with morphine sulphate. J Clin Invest 1943; 22:871-5
3. Berkowitz BA, Ngai SH, Finck AD: Nitrous oxide "analgesia": resemblance to opiate action. Science 1976; 194:967-8
4. Berkowitz BA, Finck AD, Ngai SH: Nitrous oxide analgesia: Reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 1977; 203:539-47
5. Chapman CR, Benedetti C: Nitrous oxide effects on cerebral evoked potential to pain: Partial reversal with a narcotic antagonist. ANESTHESIOLOGY 1979; 51:135-8
6. Lawrence D, Livingston A: Opiate-like analgesic activity in general anaesthetics. Br J Pharmacol 1981; 73:435-42
7. Yang JC, Clark WC, Ngai SH: Antagonism of nitrous oxide analgesia by naloxone in man. ANESTHESIOLOGY 1980; 52:414-7
8. Berkowitz BA, Finck AD, Hynes MD, Ngai SH: Tolerance to nitrous oxide analgesia in rats and mice. ANESTHESIOLOGY 1979; 51:309-12
9. Quock RM, Kouchich FJ, Tseng LF: Does nitrous oxide induce release of brain opioid peptides? Pharmacology 1985; 30:95-9
10. Zuniga JR, Joseph SA, Knigge KM: The effects of nitrous oxide on the central endogenous pro-opiomelanocortin system in the rat. Brain Res 1987; 420:57-65
11. Zuniga JR, Joseph SA, Knigge KM: The effects of nitrous oxide on the secretory activity of pro-opiomelanocortin peptides from basal hypothalamic cells attached to cytodex beads in a superfusion in vitro system. Brain Res 1987; 420:66-72
12. 7 into canine third ventricular cerebrospinal fluid. Anesth Analg 1995; 80:664-70
13. Yeung JC, Yaksh TL, Rudy TA: Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain 1977; 4:23-40
14. Fang F, Guo TZ, Davies MF, Maze M: Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur J Pharmacol 1997; 336:137-41
15. Hodges BL, Gagnon MJ, Gillespie TR, Breneisen JR, O'Leary DF, Hara S, Quock RM: Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade. J Pharmacol Exp Ther 1994; 269:596-600
16. Camarata PJ, Yaksh TL: Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection of morphine into the periaqueductal gray. Brain Res 1985; 336:133-42
17. Bylund DB: Subtypes of alpha 1- and alpha 2-adrenergic receptors. Faseb J 1992; 6: 832-9
18. Ordway GA, Jaconetta SM, Halaris AE: Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J Pharmacol Exp Ther 1993; 264:967-76
19. Wamsley JK, Alburges ME. Hunt MA, Bylund DB: Differential localization of alpha 2-adrenergic receptor subtypes in brain. Pharmacol Biochem Behav 1992; 41:267-73
20. Lawhead RG, Blaxall HS, Bylund DB: Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. ANESTHESIOLOGY 1992; 77:983-91
21. De Vos H, Bricca G, De Keyser J, De Backer JP, Bousquet P, Vauquelin G: Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system. Neuroscience 1994; 59:589-98
22. Handy DE, Flordellis CS. Bogdanova NN, Bresnahan MR. Gavras H: Diverse tissue expression of rat alpha 2-adrenergic receptor genes. Hypertension 1993; 21:861-5
23. 3H-RX821002 ligand binding. Pharmacol Toxicol 1991; 69:341-50
24. Zeng D, Lynch KR: Distribution of alpha2-adrenergic receptor mRNAs in the rat CNS. Mol Brain Res 1991; 10:219-25
25. Scheinin M, Lomasney JW, Hayden-Hixson DM: Distribution of alpha 2 adrenergic receptor subtype gene expression in rat brain. Mol Brain Res 1994; 21:133-49
26. Nicholas AP, Pieribone V, Hokfelt T: Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: An in situ hybridization study. J Comp Neurol 1993; 328:575-94
27. Lakhlani PP, MacMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, Limbird LE: Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 1997; 94:9950-5
28. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE: Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 1996; 273:801-3
29. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK: Cardiovascular regulation in mice lacking alpha 2-adrenergic receptor subtypes B and C. Science 1996; 273:803-5
30. Surprenant A, Horstman DA, Akbarali H, Limbird LE: A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992; 257:977-80
31. Hammond D: Inferences of pain and its modulation from simple behaviors. Adv Pain Res Ther 1989; 12:69-92
32. Guo TZ, Poree L, Golden W. Stein J. Fujinaga M, Maze M: Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat. ANESTHESIOLOGY 1996; 85:846-52
33. Hieble JP, Ruffolo RR: Subclassification and nomenclature of alpha 1- and alpha 2-adrenoceptors. Prog Drug Res 1996; 47:81-130
34. Bylund DB, Eikenberg DC. Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U: International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994; 46:121-35
35. Koller BH, Smithies O: Altering genes in animals by gene targeting. Ann Rev Immunol 1992; 10:705-30
36. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383:819-23
37. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE: Pain measurement: An overview. Pain 1985; 22:1-31
38. Stone LS, MacMillan LB, Kitto KF, Limbird LE, Wilcox GL: The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 1997; 17:7157-65
39. Mizobe T, Maghsoudi K, Sitwala K, Tianzhi G, Ou J, Maze M: Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat. J Clin Invest 1996; 98:1076-80 (Jackson Labs, Bar Harbor, ME)